November 26, 2015
Recommended Topic Related To:


"Dec. 24, 2014 -- America's sweet tooth is coming under fire.

Faced with mounting evidence about sugar's harms, the 2015 Dietary Guidelines Advisory Committee this month recommended that people in the U.S. limit added sugars to a maximum of "...

Liposyn II



In the event of fat overload during therapy, stop the infusion of Liposyn II (Intravenous Fat Emulsion) until visual inspection of the plasma, determination of triglyceride concentrations, or measurement of plasma light-scattering activity by nephelometry indicates the lipid has cleared. Re-evaluate the patient and institute appropriate corrective measures. See WARNINGS and PRECAUTIONS.


The administration of Liposyn II (Intravenous Fat Emulsion) is contraindicated in patients demonstrating disturbances in normal fat metabolism such as pathologic hyperlipemia, lipoid nephrosis or acute pancreatitis if accompanied by hyperlipemia.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 1/30/2009


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Weight Loss Wisdom

Get tips, recipes and inspiration.